PNC
59
3
LYB
44
3
V
40
4
MHK
27
-3
MDLZ
34
4
RHI
40
3
PCG
54
-4
CVS
52
2
SJM
19
2
DG
57
7
MAC
53
2
AMGN
39
-5
CNP
70
2
PSX
70
-4
VIX
38
-3
FRT
45
2
DD
41
-3
TSN
58
2
A
37
3
AMZN
42
-2
PNC
59
3
LYB
44
3
V
40
4
MHK
27
-3
MDLZ
34
4
RHI
40
3
PCG
54
-4
CVS
52
2
SJM
19
2
DG
57
7
MAC
53
2
AMGN
39
-5
CNP
70
2
PSX
70
-4
VIX
38
-3
FRT
45
2
DD
41
-3
TSN
58
2
A
37
3
AMZN
42
-2
Financhill
Back

Appili Therapeutics, Inc. 10K Form

Sell
29

APLIF
Appili Therapeutics, Inc.

Last Price:
$0.0112
Seasonality Move:
-31.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APLIF News And Ratings

See the #1 stock for the next 7 days that we like better than APLIF

APLIF Financial Statistics

Sales & Book Value

Annual Sales: $72.2K
Cash Flow: $-202.8K
Price / Cash Flow: 3.29
Annual Sales: $-0.09
Price / Book: 0

Profitability

EPS (TTM): -0.01720
Net Income (TTM): $-2.1M
Gross Margin: $62.5K
Return on Equity: 0%
Return on Assets: -181.18%

Appili Therapeutics, Inc. Earnings Forecast

Key Appili Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 4 years for APLIF is 86.57%.
  • The Selling, General & Administrative Expenses for APLIF have been equal to 2,841.14% of Gross Profit Margin.
  • The Research & Development expenses have been 7,303.32% of Revenue.
  • The Net Earning history of APLIF is -2,613.57% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 3 years.

Appili Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: APLIF
Website: appilitherapeutics.com

Debt

Debt-to-Equity Ratio: -0.76
Current Ratio: 0.03
Quick Ratio: 0.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APLIF Technical Analysis vs Fundamental Analysis

Sell
29
Appili Therapeutics, Inc. (APLIF) is a Sell

Is Appili Therapeutics, Inc. a Buy or a Sell?